Article
Author(s):
Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care.
Personalized inpatient assessments prior to prescribing asthma therapy to pediatric patients can improve the accuracy and quality of care, according to a new study published in Hospital Pediatrics.1
According to the study, streamlined patient care decision tools, an electronic medical record system, and access to a mobile phone application to guide each patient’s personalized care can assist health care providers in determining the best therapy for each patient.
The study found that asking these 6 key questions can be effective in accurately prescribing the right medication therapy:
In each week of 2015-2016, the first 5 pediatric patients discharged with status asthmaticus were reviewed for documentation of the 6 asthma control questions and the accuracy of the discharge controller therapy. Correct discharge medication was defined as being prescribed the age-appropriate medication and dose on the basis of baseline controller therapy, compliance with baseline medication, and response to asthma control assessment.
Overall, a total of 240 pre-intervention and 252 post-intervention charts were reviewed. Patients discharged with appropriate controller therapy improved from 60% in pre-intervention data to 80% in the post-intervention period.
The study improved the frequency of asking the questions from 40% to 98%.
“The key to caring for pediatric asthma patients is that the most appropriate medication at the right dosage must be prescribed, and the child has to take their medication every day,” Alexander Hogan, MD, assistant professor in the Department of Pediatrics at UConn School of Medicine, said in a press release about the study.2
Additionally, Dr. Hogan noted these counseling tips for children with persistent asthma:
Poorly-controlled asthma can increase chances of missed days of school, emergency room visits, and hospital readmissions. Sticking to these key decision-making tools can allow health care providers to effectively and consistently improve quality of care.
“While it is challenging to be consistent on the frontlines of medicine, providers can’t forget to ask these key questions that are an important part of the asthma patient care puzzle,” Dr. Hogan said.2
Reference
FDA Approves Ustekinumab-kfce as Sixth Biosimilar to Stelara